Bill of Health
SEPTEMBER 28, 2023
By Nikhil Chaudhry and Reshma Ramachandran Earlier this month, the Department of Health and Human Services announced that it had successfully included a reasonable pricing provision in a $326M investment contract with Regeneron for development of a next generation monoclonal antibody therapy for COVID-19. pharmaceutical market.
Health Populi
JANUARY 5, 2021
When he led Turing Pharmaceuticals in 2015, he acquired a license for the drug Daraprim (an anti-malarial therapy also used for HIV/AIDS), raising the drug price from $13.50 2: Moderna, funded with nearly $1 billion in taxpayer dollars to develop a COVID-19 vaccine, sets the highest prevailing market price for the product.
Bill of Health
MARCH 9, 2023
As to the claim of ineffectiveness, there is more than enough evidence by ordinary epidemiologic standards to license the conclusion that mask mandates are an effective intervention for pandemic response and control). Rather, the more important mistake is that these propositions are actually the warrant for mask mandates.
Expert insights. Personalized for you.
205 
Let's personalize your content